1. Inhibition of histone methyltransferase G9a aggravates phenotypic severity of hepatic lipotoxicity in non-alcoholic steatohepatitis (NASH).
- Author
-
Rajak S, Shah A, Yadav A, Shahi A, Raza S, Singh MM, Chaturvedi CP, and Sinha RA
- Subjects
- Animals, Humans, Male, Mice, Hep G2 Cells, Histocompatibility Antigens metabolism, Histocompatibility Antigens genetics, Apoptosis, Palmitic Acid pharmacology, Palmitic Acid toxicity, Hepatic Stellate Cells metabolism, Hepatic Stellate Cells pathology, Hepatic Stellate Cells drug effects, Phenotype, Transforming Growth Factor beta metabolism, Non-alcoholic Fatty Liver Disease metabolism, Non-alcoholic Fatty Liver Disease pathology, Histone-Lysine N-Methyltransferase metabolism, Histone-Lysine N-Methyltransferase antagonists & inhibitors, Histone-Lysine N-Methyltransferase genetics, Mice, Inbred C57BL, Liver metabolism, Liver pathology
- Abstract
Lipotoxicity is a key pathological feature in the development of non-alcoholic steatohepatitis (NASH), which is characterized by liver injury, inflammation, and fibrosis. Although lipotoxicity has been shown to induce transcriptomic alterations in liver cells, the specific role of epigenetic regulators in NASH remains elusive. In this study, we demonstrate that pharmacological inhibition of histone methyltransferase G9a significantly worsens NASH progression in mice, as evidenced by increased hepatic cell death, inflammation, and fibrosis. Additionally, at a cellular level both genetic and pharmacological inhibition of G9a in HepG2 cells increased their susceptibility to palmitic acid-induced apoptosis and sub-cellular stress. Furthermore, treatment with G9a inhibitor enhanced TGF-β induced activation of primary human hepatic stellate cells (hHSCs), implicating the role of G9a in NASH pathobiology., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2025
- Full Text
- View/download PDF